Company Description

eXoZymes, Inc., a development stage company, focuses on building a technology platform to develop assets that can be reapplied multiple times in various markets with only small changes, while maintaining and capturing new fundamental IP in the application.

The company produces chemicals, including pharmaceuticals, fuels, materials, food additives, colors, fragrances, and novel compounds.

Its platform also comprises one or more modules which consist of one or more enzymes that work together to perform a defined biocatalytic conversion.

The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025.

eXoZymes, Inc. was founded in 2014 and is headquartered in Monrovia, California.

eXoZymes, Inc.

Country	United States
Founded	2014
Industry	Biotechnology
Sector	Healthcare
Employees	31
CEO	Michael Heltzen

Contact Details

Address: 750 Royal Oaks Drive, Suite 106 Monrovia, California 91016 United States
Phone	626 415 1488
Website	exozymes.com

Stock Details

Ticker Symbol	EXOZ
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0002010788
ISIN Number	US4618741098

Key Executives

Name	Position
Michael Heltzen	President and Chief Executive Officer
Dr. Tyler Korman Ph.D.	Co-Founder and Vice President of Research
Dr. Paul Opgenorth Ph.D.	Co-Founder and Vice President of Development
Fouad Nawaz	Vice President of Finance
James U. Bowie Ph.D.	Founder and Independent Director
Lasse H. Gorlitz	Vice President of Communications
Michael Burns	Executive Vice President of Energy Transition
Dr. Zachary Karl Ph.D.	Vice President and Head of Business Development
Damien A. Perriman	Chief Commercial Officer